Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial

Enrico Fabris, Arnoud van't Hof, Christian W. Hamm, Frederic Lapostolle, Jens Flensted Lassen, Shaun G. Goodman, Jurrien M. ten Berg, Leonardo Bolognese, Angel Cequier, Mohamed Chettibi, Christopher J. Hammett, Kurt Huber, Magnus Janzon, Bela Merkely, Robert F. Storey, Uwe Zeymer, Warren J. Cantor, Mathieu Kerneis, Abdourahmane Diallo, Eric VicautGilles Montalescot*, ATLANTIC Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E369-E377
Number of pages9
JournalCatheterization and Cardiovascular interventions
Volume93
Issue number7
DOIs
Publication statusPublished - 1 Jun 2019

Keywords

  • antithrombotic drug
  • diabetes mellitus
  • STEMI
  • ticagrelor
  • ACUTE CORONARY SYNDROMES
  • PLATELET INHIBITION
  • CLOPIDOGREL
  • OUTCOMES
  • REACTIVITY
  • MELLITUS

Cite this

Fabris, E., van't Hof, A., Hamm, C. W., Lapostolle, F., Lassen, J. F., Goodman, S. G., ten Berg, J. M., Bolognese, L., Cequier, A., Chettibi, M., Hammett, C. J., Huber, K., Janzon, M., Merkely, B., Storey, R. F., Zeymer, U., Cantor, W. J., Kerneis, M., Diallo, A., ... ATLANTIC Investigators (2019). Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial. Catheterization and Cardiovascular interventions, 93(7), E369-E377. https://doi.org/10.1002/ccd.27921